These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 35962540)

  • 1. Association between early chronic methicillin-susceptible Staphylococcus aureus colonization and lung function in children with cystic fibrosis.
    Sunman B; Yalcin E; Ozsezen B; Tural DA; Buyuksahin HN; Guzelkas I; Emiralioglu N; Dogru D; Özçelik U; Şener B; Kiper N
    Pediatr Pulmonol; 2022 Dec; 57(12):2963-2970. PubMed ID: 35962540
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact at school age of early chronic methicillin-sensitive Staphylococcus aureus infection in children with cystic fibrosis.
    Galodé F; Dournes G; Chateil JF; Fayon M; Collet C; Bui S
    Pediatr Pulmonol; 2020 Oct; 55(10):2641-2645. PubMed ID: 32543758
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence and clinical associations of Staphylococcus aureus small-colony variant respiratory infection in children with cystic fibrosis (SCVSA): a multicentre, observational study.
    Wolter DJ; Onchiri FM; Emerson J; Precit MR; Lee M; McNamara S; Nay L; Blackledge M; Uluer A; Orenstein DM; Mann M; Hoover W; Gibson RL; Burns JL; Hoffman LR;
    Lancet Respir Med; 2019 Dec; 7(12):1027-1038. PubMed ID: 31727592
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical impact of Achromobacter xylosoxidans colonization/infection in patients with cystic fibrosis.
    Firmida MC; Pereira RH; Silva EA; Marques EA; Lopes AJ
    Braz J Med Biol Res; 2016; 49(4):e5097. PubMed ID: 26909788
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between Staphylococcus aureus alone or combined with Pseudomonas aeruginosa and the clinical condition of patients with cystic fibrosis.
    Hubert D; Réglier-Poupet H; Sermet-Gaudelus I; Ferroni A; Le Bourgeois M; Burgel PR; Serreau R; Dusser D; Poyart C; Coste J
    J Cyst Fibros; 2013 Sep; 12(5):497-503. PubMed ID: 23291443
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Presence of methicillin resistant Staphylococcus aureus in respiratory cultures from cystic fibrosis patients is associated with lower lung function.
    Ren CL; Morgan WJ; Konstan MW; Schechter MS; Wagener JS; Fisher KA; Regelmann WE;
    Pediatr Pulmonol; 2007 Jun; 42(6):513-8. PubMed ID: 17469151
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk factors associated with pulmonary exacerbations in pediatric patients with cystic fibrosis.
    Lubovich S; Zaragoza S; Rodríguez V; Buendía J; Camargo Vargas B; Alchundia Moreira J; Galanternik L; Ratto P; Teper A
    Arch Argent Pediatr; 2019 Oct; 117(5):e466-e472. PubMed ID: 31560491
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The clinical presentations of pulmonary aspergillosis in children with cystic fibrosis - preliminary report.
    Walicka-Serzysko K; Sands D
    Dev Period Med; 2015; 19(1):66-79. PubMed ID: 26003072
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of pancreatic status, CFTR mutations, Staphylococcus aureus and/or Pseudomonas aeruginosa infection/colonization on lung function in cystic fibrosis during a 2-year follow-up period.
    Pascoal MA; Marson FAL; Paschoal IA; Levy CE
    Wien Klin Wochenschr; 2020 Oct; 132(19-20):572-580. PubMed ID: 32356101
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Methicillin-resistant Staphylococcus aureus in patients with cystic fibrosis].
    Girón RM; Buendía B; Pinedo C; Casanova A; Hoyos N; Ancochea J
    Enferm Infecc Microbiol Clin; 2009 Feb; 27(2):85-8. PubMed ID: 19254640
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence and impact on FEV(1) decline of chronic methicillin-resistant Staphylococcus aureus (MRSA) colonization in patients with cystic fibrosis. A single-center, case control study of 165 patients.
    Vanderhelst E; De Meirleir L; Verbanck S; Piérard D; Vincken W; Malfroot A
    J Cyst Fibros; 2012 Jan; 11(1):2-7. PubMed ID: 21907637
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rationale and design of a randomized trial of home electronic symptom and lung function monitoring to detect cystic fibrosis pulmonary exacerbations: the early intervention in cystic fibrosis exacerbation (eICE) trial.
    Lechtzin N; West N; Allgood S; Wilhelm E; Khan U; Mayer-Hamblett N; Aitken ML; Ramsey BW; Boyle MP; Mogayzel PJ; Goss CH
    Contemp Clin Trials; 2013 Nov; 36(2):460-9. PubMed ID: 24055998
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early assessment of glucose abnormalities during continuous glucose monitoring associated with lung function impairment in cystic fibrosis patients.
    Leclercq A; Gauthier B; Rosner V; Weiss L; Moreau F; Constantinescu AA; Kessler R; Kessler L
    J Cyst Fibros; 2014 Jul; 13(4):478-84. PubMed ID: 24359972
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pulmonary function and clinical course in patients with cystic fibrosis after pulmonary colonization with Pseudomonas aeruginosa.
    Kerem E; Corey M; Gold R; Levison H
    J Pediatr; 1990 May; 116(5):714-9. PubMed ID: 2109790
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk factors and clinical course of children with cystic fibrosis colonized with Staphylococcus aureus.
    Ghimire JJ; Gulla KM; Jat KR; Sankar J; Lodha R; Kabra SK
    Trans R Soc Trop Med Hyg; 2021 Jul; 115(7):801-806. PubMed ID: 33179055
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment for chronic methicillin-sensitive Staphylococcus aureus pulmonary infection in people with cystic fibrosis.
    Ahmed MI; Mukherjee S
    Cochrane Database Syst Rev; 2018 Jul; 7(7):CD011581. PubMed ID: 30052271
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment for chronic methicillin-sensitive Staphylococcus aureus pulmonary infection in people with cystic fibrosis.
    Ahmed MI; Mukherjee S
    Cochrane Database Syst Rev; 2016 Mar; 3():CD011581. PubMed ID: 27003247
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of nutritional status, plasma, albumin levels and pulmonary function in cystic fibrosis.
    Souza dos Santos Simon MI; Drehmer M; de Abreu E Silva FA; Hoffmann A; Druck Ricachinewsky C; de Fonseca Andrade Procianoy E; Scattolin I; Saldanha Menna Barreto S
    Nutr Hosp; 2011; 26(6):1322-7. PubMed ID: 22411378
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of Pseudomonas aeruginosa eradication regimens on chronic colonization and clinical outcomes in pediatric patients with cystic fibrosis.
    Nayir Buyuksahin H; Yalçın E; Emiralioglu N; Hazırolan G; Ademhan Tural D; Ozsezen B; Sunman B; Guzelkas I; Dogru D; Ozcelik U; Kiper N
    Pediatr Int; 2022 Jan; 64(1):e15249. PubMed ID: 36321341
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pulmonary artery enlargement and cystic fibrosis pulmonary exacerbations: a cohort study.
    Wells JM; Farris RF; Gosdin TA; Dransfield MT; Wood ME; Bell SC; Rowe SM
    Lancet Respir Med; 2016 Aug; 4(8):636-645. PubMed ID: 27298019
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.